Preoperative management of blood thinning agents during cutaneous surgery: The need for an individualized approach - 05/12/20
Doi : 10.1016/j.jaad.2020.08.075
Sareena Gajebasia, BMBS, iBSc(Hons) a, ⁎ 
, Ron Kerr, MBChB, MRCP, FRCPath, MD b, Andrew Affleck, MBChB, MRCP a
, Ron Kerr, MBChB, MRCP, FRCPath, MD b, Andrew Affleck, MBChB, MRCP a a Department of Dermatology, Ninewells Hospital, Dundee, United Kingdom
b Department of Haematology, Ninewells Hospital, Dundee, United Kingdom
∗Correspondence to: Sareena Gajebasia, BMBS, iBSc(Hons), Department of Dermatology, Level 8, Ninewells Hospital, James Arrott Drive, Dundee, DD1 9SYDepartment of DermatologyLevel 8, Ninewells HospitalJames Arrott DrDundeeDD1 9SY
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 1
P. e41-e42 - janvier 2021 Retour au numéro
Article précédent
- Reply to: “Comment on ‘Razor blade, a simple instrument used in epidermic grafting for vitiligo’”
- Kai Huang, Jinmao Li, Zixi Jiang, Hui Fan, Nianzhou Yu, Dihui Liu, Juan Su, Shuang Zhao, Xiang Chen
- Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma
- Khan Sharun, Abhijit M. Pawde
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?